Mahmoud Gimie
Examiner (ID: 4016, Phone: (571)272-4841 , Office: P/3747 )
Most Active Art Unit | 3747 |
Art Unit(s) | 3747 |
Total Applications | 3316 |
Issued Applications | 2860 |
Pending Applications | 127 |
Abandoned Applications | 328 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18070477
[patent_doc_number] => 11529292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Compositions in the form of dissolvable solid structures
[patent_app_type] => utility
[patent_app_number] => 17/838692
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 14456
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838692
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838692 | Compositions in the form of dissolvable solid structures | Jun 12, 2022 | Issued |
Array
(
[id] => 18152068
[patent_doc_number] => 11565018
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-01-31
[patent_title] => Method of oral hemostasis using a conformable non-disruptive hemostasis material
[patent_app_type] => utility
[patent_app_number] => 17/391108
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 4473
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/391108 | Method of oral hemostasis using a conformable non-disruptive hemostasis material | Aug 1, 2021 | Issued |
Array
(
[id] => 17997644
[patent_doc_number] => 11498735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Array of wet wipe packages
[patent_app_type] => utility
[patent_app_number] => 17/373829
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12079
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373829 | Array of wet wipe packages | Jul 12, 2021 | Issued |
Array
(
[id] => 18101122
[patent_doc_number] => 11540988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Wet wipes comprising a lotion
[patent_app_type] => utility
[patent_app_number] => 17/333213
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9905
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333213
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/333213 | Wet wipes comprising a lotion | May 27, 2021 | Issued |
Array
(
[id] => 18151938
[patent_doc_number] => 11564887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Process for the production of compressed tablets
[patent_app_type] => utility
[patent_app_number] => 17/237976
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4412
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237976
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237976 | Process for the production of compressed tablets | Apr 21, 2021 | Issued |
Array
(
[id] => 17334870
[patent_doc_number] => 20220001201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => Method for Treating Cancerous and Pre-Cancerous Skin
[patent_app_type] => utility
[patent_app_number] => 17/183654
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183654
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/183654 | Method for treating cancerous and pre-cancerous skin | Feb 23, 2021 | Issued |
Array
(
[id] => 18133952
[patent_doc_number] => 11559601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Hemostatic devices
[patent_app_type] => utility
[patent_app_number] => 17/179013
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 19900
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179013 | Hemostatic devices | Feb 17, 2021 | Issued |
Array
(
[id] => 18171678
[patent_doc_number] => 11571370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Antifungal solution and wipe
[patent_app_type] => utility
[patent_app_number] => 17/170375
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7592
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170375
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170375 | Antifungal solution and wipe | Feb 7, 2021 | Issued |
Array
(
[id] => 16976026
[patent_doc_number] => 20210220263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/146909
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146909 | CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS | Jan 11, 2021 | Abandoned |
Array
(
[id] => 17005254
[patent_doc_number] => 20210236415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => SYNTHESIS AND APPLICATION OF MICROBUBBLE-FORMING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/079381
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/079381 | Synthesis and application of microbubble-forming compounds | Oct 22, 2020 | Issued |
Array
(
[id] => 16569237
[patent_doc_number] => 20210008243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => PLASMA-BASED FILMS AND METHODS FOR MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/032331
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/032331 | Plasma-based films and methods for making and using the same | Sep 24, 2020 | Issued |
Array
(
[id] => 16374378
[patent_doc_number] => 20200323220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => BIOCIDAL PESTICIDE COMPOSITION SUSPENDED IN A PLANT OIL BASED EMULSION AND MANUFACTURING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/912404
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16912404
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/912404 | BIOCIDAL PESTICIDE COMPOSITION SUSPENDED IN A PLANT OIL BASED EMULSION AND MANUFACTURING METHOD THEREOF | Jun 24, 2020 | Abandoned |
Array
(
[id] => 16175343
[patent_doc_number] => 20200222311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => SYNTHESIS AND APPLICATION OF MICROBUBBLE-FORMING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/831781
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 396
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/831781 | Synthesis and application of microbubble-forming compounds | Mar 25, 2020 | Issued |
Array
(
[id] => 16998441
[patent_doc_number] => 11077223
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-08-03
[patent_title] => Method of oral hemostasis using a conformable non-disruptive hemostasis material
[patent_app_type] => utility
[patent_app_number] => 16/830551
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 4455
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16830551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/830551 | Method of oral hemostasis using a conformable non-disruptive hemostasis material | Mar 25, 2020 | Issued |
Array
(
[id] => 16052917
[patent_doc_number] => 20200188313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/796189
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796189 | LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF | Feb 19, 2020 | Abandoned |
Array
(
[id] => 16052995
[patent_doc_number] => 20200188352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
[patent_app_type] => utility
[patent_app_number] => 16/796194
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796194
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796194 | ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | Feb 19, 2020 | Abandoned |
Array
(
[id] => 15894859
[patent_doc_number] => 20200146948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => URETHANE FOAM FOR USE IN IMPREGNATING COSMETIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/745694
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16745694
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/745694 | Urethane foam for use in impregnating cosmetic composition | Jan 16, 2020 | Issued |
Array
(
[id] => 16680666
[patent_doc_number] => 10940122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Transdermal therapeutic system with fentanyl or related substances
[patent_app_type] => utility
[patent_app_number] => 16/719086
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2842
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/719086 | Transdermal therapeutic system with fentanyl or related substances | Dec 17, 2019 | Issued |
Array
(
[id] => 16861887
[patent_doc_number] => 11020609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Methods and compositions for treatment of pigmented lesions
[patent_app_type] => utility
[patent_app_number] => 16/693840
[patent_app_country] => US
[patent_app_date] => 2019-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6320
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/693840 | Methods and compositions for treatment of pigmented lesions | Nov 24, 2019 | Issued |
Array
(
[id] => 16397175
[patent_doc_number] => 20200338033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/684000
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/684000 | Enterically coated cysteamine, cystamine and derivatives thereof | Nov 13, 2019 | Issued |